Rivaroxaban’s Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029619868535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Personalizing Bridging Anticoagulation in Patients With Nonvalvular Atrial Fibrillation—a Microsimulation Analysis

Journal of General Internal Medicine
Internal Medicine
2017English

Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation

International Heart Journal
MedicineCardiovascular MedicineCardiology
2006English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation

Archives of Internal Medicine
1998English

Comparative Effectiveness and Safety of Warfarin and Dabigatran in Patients With Non-Valvular Atrial Fibrillation in Japan: A Claims Database Analysis

Journal of Cardiology
Cardiovascular MedicineCardiology
2019English

Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients With Nonvalvular Atrial Fibrillation

Journal of Nihon University Medical Association
2016English

Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation

JAMA network open
Medicine
2020English

Risk Stratification of Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2013English

Characterization of circRNA‑associated ceRNA Networks in Patients With Nonvalvular Persistent Atrial Fibrillation

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy